ISMP is taking a formal stand on the need to eliminate any remaining barriers to a standardized appearance of bioequivalent brand and generic medications. In a recent ABC News special on generic ...

BEECH ISLAND, S.C.--(BUSINESS WIRE)--Ambio, Inc., an innovative biotech company developing novel peptide drugs, biosimilar, bioequivalent, and other complex generic drugs, announced today that a ...

This article provides an overview of the regulatory regime and associated intellectual property rights for veterinary drug ...

Lupin has launched its generic Dapagliflozin and Metformin extended-release tablets in the US after USFDA approval, strengthening its presence in the diabetes therapeutics segment and expanding its ...